Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Generic screening for breast cancer].

A Ponti1, L Giordano

  • 1Dipartimento di Oncologia dell'Ospedale S. Giovanni Antica Sede, A.S.L.1, Torino.

Epidemiologia E Prevenzione
|March 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT study.

Breast (Edinburgh, Scotland)·2026
Same author

Biochemical fingerprinting of dried blood serum from chronic lymphocytic leukemia patients by Raman spectroscopy: Towards prognostic classification.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

UBA5-epileptic encephalopathy: new patient, a novel variant, and a review of epileptic phenotypes.

Epileptic disorders : international epilepsy journal with videotape·2025
Same author

Determinants of sustainable adoption in primary care of a clinical decision support system for antimicrobial prescribing: A qualitative study.

Infectious diseases now·2025
Same author

Retrospective multicenter study on cryptogenic NORSE/FIRES patients treated with anakinra.

Seizure·2025
Same author

Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790].

Breast (Edinburgh, Scotland)·2025

Genetic screening for BRCA1 and BRCA2 mutations may benefit high-risk women. Further research is needed on mutation penetrance, prevalence, influencing factors, and the effectiveness of preventive strategies.

Area of Science:

  • Genetics and Oncology
  • Cancer Epidemiology

Context:

  • Advancements in genetic sequencing identified BRCA1 and BRCA2 genes.
  • Familial breast cancer risk assessment is a growing clinical concern.

Purpose:

  • To determine the utility of genetic screening for BRCA1 and BRCA2 mutations in high-risk women.
  • To identify key areas for future research in hereditary breast cancer.

Summary:

  • Further investigation is required into BRCA1 and BRCA2 mutation penetrance and population prevalence.
  • Understanding biological, environmental, and natural history factors is crucial for carriers.
  • Research on preventive measures, genetic counseling, and psychological impacts of testing is essential.

Impact:

Related Experiment Videos

  • Informs clinical guidelines for genetic testing in hereditary breast cancer.
  • Guides future research priorities for BRCA1/BRCA2 mutation carriers.
  • Aims to improve risk assessment and management for women with familial cancer risk.